RISK OF TREATMENT ESCALATION IN RECIPIENTS VS NONRECIPIENTS OF SPINAL MANIPULATION FOR MUSCULOSKELETAL CERVICAL SPINE DISORDERS: AN ANALYSIS OF INSURANCE CLAIMS
 
   

Risk of Treatment Escalation in Recipients vs Nonrecipients of
Spinal Manipulation for Musculoskeletal Cervical Spine Disorders:
An Analysis of Insurance Claims

This section is compiled by Frank M. Painter, D.C.
Send all comments or additions to:
    Frankp@chiro.org
 
   

FROM:   J Manipulative Physiol Ther 2021 (Jun); 44 (5): 372–377


Brian R Anderson • W Steve McClellan • Cynthia R Long

Palmer Center for Chiropractic Research,
Palmer College of Chiropractic,
Davenport, Iowa.


Objective:   The purpose of this study was to evaluate the relationship between treatment escalation and spinal manipulation in a retrospective cohort of people diagnosed with musculoskeletal disorders of the cervical spine.

Methods:   We used retrospective analysis of insurance claims data (2012-2018) from a single Fortune 500 company. After isolating the first episode of care, we categorized 58 147 claims into 7951 unique patient episodes. Treatment escalation included claims where imaging, injection, emergency room, or surgery was present. Modified Poisson regression was used to determine the relative risk of treatment escalation comparing recipients vs nonrecipients of spinal manipulation, adjusted for age, sex, episode duration, and risk scores.

Results:   The sample was 55% women, with a mean age of 44 years (range, 18-103). Treatment escalation was present in 42% of episodes overall: 2448 (46%) associated with other care and 876 (26%) associated with spinal manipulation. The estimated risk of any treatment escalation was 2.38 times higher in those who received other care than in those who received spinal manipulation (95% confidence interval, 2.22-2.55, P = .001).

Conclusion:   Among episodes of care associated with neck pain diagnoses, those associated with other care had twice the risk of any treatment escalation compared with those associated with spinal manipulation. In the United States, over 90% of spinal manipulation is provided by doctors of chiropractic; therefore, these findings are relevant and should be considered in addressing solutions for neck pain. Additional research investigating the factors influencing treatment escalation is necessary to moderate the use of high-cost and guideline-incongruent procedures in people with neck pain.

Keywords:   Chiropractic; Insurance; Manipulation, Spinal; Neck Pain; Patients; Risk.



From the FULL TEXT Article:

INTRODUCTION

Neck pain has been among the top 10 leading causes of global disability every decade since 1990, [1] and combined with low back pain, it is the leading cause of health care expenditures in the United States, at $135 billion. [2] The global age-standardized point prevalence of neck pain is approximately 3.5%. [3] Clinical practice guidelines for the management of neck pain recommend education, self-management, exercise, manipulation and mobilization, and nonopioid analgesics; the majority of these guidelines do not differentiate based on the duration of neck pain. [4] Despite recommendations against the routine use of imaging, opioid medications, injection procedures, and surgery, the use of these procedures has increased exponentially since 2000. [5-8] The use of high-cost and guideline-incongruent procedures significantly contributes to the costs associated with treatment of spinal pain disorders. [9]

Treatment escalation is defined as increasing the complexity of care in the management of a disease, as well as any care necessary beyond the “usual” treatment a person uses to manage their condition. [10] Treatment escalation is known to occur with a variety of conditions, including asthma, [11] eczema, [12] cancer, [13] end-of-life care,14 and use of medications such as antibiotics. [15] However, the concept has only briefly been described in the literature on musculoskeletal disorders. [16]

Individuals with neck pain commonly seek care from primary care physicians, but they also routinely visit chiropractors, physical therapists, and medical specialists. [17] A 2018 Gallup poll [18] indicated that 32% of US adults had seen a health care professional for neck or low back pain in the past 12 months, and that 53% of that population visited a doctor of chiropractic. The provider’s scope of practice and training play an important role in the care delivered. Doctors of chiropractic do not prescribe medication or perform invasive treatment such as injections or surgery. Instead, they typically provide manual therapies, therapeutic exercise, lifestyle advice, and other conservative therapies. [19] In the United States, over 90% of spinal manipulation is provided by doctors of chiropractic. [20]

The primary aim of this project was to evaluate the relationship between treatment escalation and type of care in episodes associated with diagnosed musculoskeletal disorders of the cervical spine by analyzing health insurance claims from a large Fortune 500 company. We hypothesized that episodes in nonrecipients of spinal manipulation (other care) would have a higher risk of treatment escalation than those in recipients of spinal manipulation.



DISCUSSION

In our study, those not receiving spinal manipulation (ie, receiving other care) had a statistically significant increased risk of treatment escalation compared to recipients of spinal manipulation. Several studies in the physical-therapy literature explore health care utilization among provider types but do not characterize it as treatment escalation. [16, 25-27] Specific to neck pain and chiropractic care, Horn et al [27] found that people with neck pain initiating care with primary care vs chiropractic physicians had higher odds of using advanced imaging, injections, and opioid medications. Although they did not investigate the use of chiropractic services per se, Nelson et al [28] evaluated the effects of insurance plans with and without chiropractic coverage on use of advanced imaging, surgery, inpatient care, and plain-film radiographs in the management of neck and low back pain. The group with chiropractic benefits had a statistically significant decrease in use of surgery (23%), advanced imaging (23%), inpatient costs (28%), and plainfilm radiography (8%).

It has been well documented in the literature that people seeking chiropractic compared to medical care have higher educational attainment, fewer comorbid conditions, more moderate disability, and better overall self-rated physical and mental health. [29-33] However, participants in our study had similar retrospective and prospective risk scores across both treatment groups. Individuals seeking chiropractic care also have a high degree of confidence in the ability of chiropractors to improve their symptoms, compared to other treatment approaches. [9] Confidence in a provider may decrease the likelihood of seeking more escalated treatment.

The scope of available therapies varies among providers managing neck pain. Potential barriers to treatment escalation exist within chiropractic — and not in medical care — due to limitations in scope of practice, as already described. Additionally, medical providers are affiliated with health organizations which allow for easy access to escalation procedures; this is typically not the case for providers using spinal manipulation. Therefore, interpreting study results is complex, and further research is necessary to determine the specific characteristics associated with treatment escalation.

      Limitations

Our data set did not include pharmaceutical claims and used a proprietary risk score index, both of which could be considered limitations. Our data set comprised privately insured members of a single Fortune 500 company, which may not be generalizable to the population at large. Although we adjusted for comorbidity via retrospective and prospective risk scores, variables such as education, level of disability, and self-reported measures of health were not available. As only the primary diagnosis was available, it is important to consider that secondary conditions could have influenced the likelihood of treatment escalation. Provider identification codes would have helped identify provider type more accurately; however, these were not available in our data set. While we cannot definitively determine the provider type administering spinal manipulation, there is a very high likelihood that these providers were chiropractors, since the majority of spinal manipulation is performed by chiropractors. [20]

There are inherent disadvantages to using existing data to answer new research questions, including unknown accuracy of billing codes, lack of outcome data, risk of unmeasured variables that may confound results, potentially flawed strategies for including or excluding specific cases, and altered use of specific services based on their coverage by the insurance plan. [34]

Treatment escalation is necessary and appropriate with some conditions, such as trauma, cervical artery dysfunction, and cancer, which require rapid escalation due to their life-threatening nature. Although these conditions are relatively rare, [35-38] it is likely that these patients will not seek spinal manipulation



CONCLUSIONS

Among episodes of care for a cohort of individuals diagnosed with neck pain, nonrecipients of spinal manipulation had more than twice the risk of any treatment escalation compared to recipients of spinal manipulation. In the United States, over 90% of spinal manipulation is provided by doctors of chiropractic; therefore, these findings are relevant and should be considered in addressing solutions for neck pain. Additional research investigating the factors influencing treatment escalation is necessary to guide decreasing the use of high-cost and guideline-incongruent procedures in people with neck pain.



References:

  1. James SL, et al.
    Global, regional, and national incidence, prevalence, and years lived with
    disability for 354 diseases and injuries for 195 countries and territories,
    1990-2017: a systematic analysis for the
    Global Burden of Disease Study 2017.
    Lancet. 2018;392:1789-1858.

  2. Dieleman JL, Cao J, Chapin A, et al.
    US Health Care Spending by Payer
    and Health Condition, 1996-2016

    JAMA 2020 (Mar 3); 323 (9): 863–884

  3. Safiri S, Kolahi A-A, Hoy D, et al.
    Global, Regional, and National Burden of Neck Pain in the
    General Population, 1990-2017: Systematic Analysis of
    the Global Burden of Disease Study 2017

    British Medical Journal 2020 (Mar 26); 368: m791

  4. Parikh P, Santaguida P, Macdermid J, Gross A, Eshtiaghi A.
    Comparison of CPG’s for the diagnosis, prognosis and management
    of non-specific neck pain: a systematic review.
    BMC Musculoskelet Disord. 2019;20:81.

  5. Beckworth WJ, Jiang M, Hemingway J, Hughes D, Staggs D.
    Facet injection trends in the Medicare population
    and the impact of bundling codes.
    Spine J. 2016;16:1037-1041.

  6. Mafi JN, McCarthy EP, Davis RB, Landon BE.
    Worsening Trends in the Management and Treatment of Back Pain
    JAMA Internal Medicine 2013 (Sep 23); 173 (17): 1573–1581

  7. Marquez-Lara A, Nandyala SV, Fineberg SJ, Singh K.
    Current trends in demographics, practice, and in-hospital outcomes
    in cervical spine surgery: a national database analysis
    between 2002 and 2011.
    Spine (Phila Pa 1976). 2014;39:476-481.

  8. Stokes A, Berry KM, Hempstead K, Lundberg DJ, Neogi T.
    Trends in prescription analgesic use among adults with musculoskeletal
    conditions in the United States, 1999-2016.
    JAMA Netw Open. 2019;2: e1917228.

  9. Allen H, Wright M, Craig T, et al.
    Tracking Low Back Problems in a Major Self-Insured Workforce:
    Toward Improvement in the Patient's Journey

    J Occup Environ Med. 2014 (Jun); 56 (6): 604-620

  10. Dahill M, Powter L, Garland L, Mallett M, Nolan J.
    Improving documentation of treatment escalation decisions in acute care.
    BMJ Qual Improv Rep. 2013;2. u200617.w1077.

  11. Sullivan PW, Campbell JD, Ghushchyan VH, Globe G.
    Outcomes before and after treatment escalation to Global Initiative
    for Asthma steps 4 and 5 in severe asthma.
    Ann Allergy Asthma Immunol. 2015;114:462-469.e6.

  12. Thomas KS, et al.
    Validation of treatment escalation as a definition
    of atopic eczema flares.
    PLoS One. 2015;10: e0124770.

  13. Regan MM, Barry WT.
    Trial designs and results supporting treatment de-escalation and escalation.
    Breast. 2017;34(suppl 1):S10-S12.

  14. Sayma M, Nowell1 G, O’Connor A, et al.
    Improving the use of treatment escalation plans:
    a quality-improvement study.
    Postgrad Med J. 2018;94:404-410.

  15. Leone M, Bechis C, Baumstarck K, et al.
    De-escalation versus continuation of empirical antimicrobial treatment
    in severe sepsis: a multicenter non-blinded
    randomized noninferiority trial.
    Intensive Care Med. 2014;40:1399-1408.

  16. Donelson R, Spratt K, McClellan WS, et al.
    The cost impact of a quality-assured mechanical assessment
    in primary low back pain care.
    J Man Manip Ther. 2019;27:277-286.

  17. Horn ME, Brennan GP, George SZ, Harman JS, Bishop MD.
    Clinical outcomes, utilization, and charges in persons with
    neck pain receiving guideline adherent physical therapy.
    Eval Health Prof. 2016;39:421-434.

  18. Palmer College of Chiropractic.
    The 2018 Gallup-Palmer College of Chiropractic Annual Report.
    Managing Neck and Back Pain in America

  19. National Board of Chiropractic Examiners.
    Practice Analysis of Chiropractic 2020.

  20. Hurwitz EL.
    Epidemiology: Spinal Manipulation Utilization
    J Electromyogr Kinesiol. 2012 (Oct); 22 (5): 648–654

  21. Symmetry Episode Treatment Groups.
    Measuring Health Care with Meaningful Episodes of Care.
    OptumInsight.

  22. Benchimol EI, Smeeth L, Guttman A, et al.
    The REporting of studies Conducted using Observational
    Routinely-collected health Data (RECORD) statement.
    PLoS Med. 2015 Oct 6; 12(10).

  23. R Core Team.
    R: a language and environment for statistical computing.
    Vienna, Austria: Foundation for Statistical Computing; 2017.

  24. Zou G.
    A modified Poisson regression approach to
    prospective studies with binary data.
    Am J Epidemiol. 2004;159:702-706.

  25. Frogner BK, Harwood K, Andrilla CHA, Schwartz M, Pines JM.
    Physical therapy as the first point of care to treat low back pain:
    an instrumental variables approach to estimate impact on opioid
    prescription, health care utilization, and costs.
    Health Serv Res. 2018;53:4629-4656.

  26. Fritz JM, Kim J, Dorius J.
    Importance of the Type of Provider Seen to Begin
    Health Care for a New Episode Low Back Pain:
    Associations with Future Utilization and Costs

    J Eval Clin Pract. 2016 (Apr); 22 (2): 247–252

  27. Horn ME, George SZ, Fritz JM.
    Influence of Initial Provider on Health Care Utilization
    in Patients Seeking Care for Neck Pain

    Mayo Clin Proc Innov Qual Out. 2017 (Oct 19); 1 (3): 226–233

  28. Nelson CF, Metz RD, LaBrot T.
    Effects of a Managed Chiropractic Benefit on the Use
    of Specific Diagnostic and Therapeutic Procedures
    in the Treatment of Low Back and Neck Pain

    J Manipulative Physiol Ther 2005 (Oct); 28 (8): 564–569

  29. Bath B, Lawson J, Ma D, Trask C.
    Self-reported Use of Family Physician, Chiropractor and
    Physiotherapy Services Among Adult Canadians with
    Chronic Back Disorders: An Observational Study

    BMC Health Serv Res 2018 (Dec 17); 18 (1): 970

  30. Broom AF, Kirby ER, Sibbritt DW, Adams J, Refshauge KM.
    Back pain amongst mid-age Australian women: a longitudinal
    analysis of provider use and self-prescribed treatments.
    Complement Ther Med. 2012;20:275-282.

  31. Cote P, Cassidy JD, Carroll L.
    The Treatment of Neck and Low Back Pain:
    Seeks Care? Who Goes Where?

    Medical Care 2001 (Sep); 39 (9): 956–967

  32. de Luca KE, Parkinson L, Haldeman S, Byles JE, Blyth F.
    The Relationship Between Spinal Pain and Comorbidity:
    A Cross-sectional Analysis of 579 Community-Dwelling,
    Older Australian Women

    J Manipulative Physiol Ther 2017 (Sep); 40 (7): 459–466

  33. Sibbritt D, et al.
    Severity of back pain may influence choice and order of practitioner
    consultations across conventional, allied and complementary health care:
    a cross-sectional study of 1851 mid-age Australian women.
    BMC Musculoskelet Disord. 2016;17:393.

  34. Johnson EK, Nelson CP.
    Utility and pitfalls in the use of administrative databases for outcomes assessment.
    J Urol. 2013;190:17-18.

  35. Greenhalgh S, Selfe J.
    Red Flags II. 1st ed. London, UK:
    Churchill Livingstone; 2009.

  36. Nouri A, Tetreault L, Singh A, Karadimas SK, Fehlings MG.
    Degenerative cervical myelopathy: epidemiology, genetics, and pathogenesis.
    Spine (Phila Pa 1976). 2015;40:E675.

  37. Blum CA, Yaghi S.
    Cervical artery dissection: a review of the epidemiology,
    pathophysiology, treatment, and outcome.
    Arch Neurosci. 2015;2(4):e26670.

  38. Milby AH, Halpern CH, Guo W, Stein SC.
    Prevalence of cervical spinal injury in trauma.
    Neurosurg Focus. 2008;25:E10.

Return to MEDICARE

Return to INITIAL PROVIDER/FIRST CONTACT

Since 2-14-2025

© 1995–2025 ~ The Chiropractic Resource Organization ~ All Rights Reserved